Staphylococcus aureus acquires resistance to glycopeptide antibiotic vancomycin via CXCL10
International Immunopharmacology · 2024
DOI: 10.1016/j.intimp.2024.111780 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Xu Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Second Hospital of Jilin University, Changchun 130022, PR China. Hauptthemen laut MEDLINE: Staphylococcus aureus, Vancomycin, Staphylococcal Infections, Anti-Bacterial Agents. Die Arbeit nennt 47 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Glycopeptide antibiotic vancomycin is a bactericidal antibiotic available for the infection to Staphylococcus aureus (SA), however, SA has a strong adaptive capacity and thereby acquires resistance to vancomycin. This study aims to illuminate the possible molecular mechanism of vancomycin resistance of SA based on the 16S rRNA sequencing data and microarray profiling data. METHODS: 16S rRNA sequencing data of control samples and urinary tract infection samples were retrieved from the EMBL-EBI (European Molecular Biology Laboratory - European Bioinformatics Institute) database. Correlation of gut flora and clinical indicators was evaluated. The possible targets regulated by SA were predicted by microarray profiling and subjected to KEGG (Kyoto Encyclopedia of Genes and Genomes) enrichment analysis. CXCL10 gene knockout and overexpression were introduced to evaluate the effect of CXCL10 on the virulence of SA and the resistance to vancomycin. SA strains were co-cultured with urethral epithelial cells in vitro. The presence of SA virulence factors was detected using PCR. Biofilm formation of SA strains was assessed using the microtiter plate method. Furthermore, the antibiotic sensitivity of SA strains was evaluated through vancomycin testing. RESULTS: Gut flora and its species abundance had significant difference between urinary tract infection and control samples. SA was significantly differentially expressed in urinary tract infection samples. Resistance of SA to vancomycin mainly linked to the D-alanine metabolism pathway. SA may participate in the occurrence of urinary tract infection by upregulating CXCL10. In addition, CXCL10 mainly affected the SA resistance to vancomycin through the TLR signaling pathway. In vitro experimental results further confirmed that the overexpression of CXCL10 in SA increased SA virulence and decreased its susceptibility to vancomycin. In vitro experimental validation demonstrated that the knockout of CXCL10 in urethral epithelial cells enhanced the sensitivity of Staphylococcus aureus (SA) to vancomycin. CONCLUSION: SA upregulates the expression of CXCL10 in urethral epithelial cells, thereby activating the TLR signaling pathway and promoting resistance to glycopeptide antibiotics in SA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, The Second Hospital of Jilin University, Changchun 130022, PR China.
- Department of Urology, The Second Hospital of Jilin University, Changchun 130022, PR China. Electronic address: fanht@jlu.edu.cn.
Zitieren
APA
Wang, X., Zhan, P., Zhang, Q., Li, R., & Fan, H. (2024). Staphylococcus aureus acquires resistance to glycopeptide antibiotic vancomycin via CXCL10. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.111780
Vancouver
Wang X, Zhan P, Zhang Q, Li R, Fan H. Staphylococcus aureus acquires resistance to glycopeptide antibiotic vancomycin via CXCL10. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.111780
BibTeX
@article{Wang2024,
author = {Wang, Xu and Zhan, Peng and Zhang, Qiushuang and Li, Ranwei and Fan, Haitao},
title = {Staphylococcus aureus acquires resistance to glycopeptide antibiotic vancomycin via CXCL10},
journal = {International Immunopharmacology},
year = {2024},
doi = {10.1016/j.intimp.2024.111780}
}
EUVIMED